Mass Torts and MDLs for Attorneys to Focus On in 2024

As we approach 2024, the legal landscape for mass torts and MDLs (Multidistrict Litigations) is brimming with potential developments. Several significant cases are set to unfold, promising substantial changes and possible high-stakes settlements. In this comprehensive overview, we delve into the key mass torts and MDLs expected to make headlines this year. If you’re navigating this complex field, consider exploring resources like Law Firm Connector, which can assist attorneys in finding clients and help clients find suitable legal representation.

Roundup (N.D. Cal. 16-md-2741)

Roundup, a herbicide manufactured by Bayer, has faced extensive legal scrutiny over allegations linking its active ingredient, glyphosate, to cancer. Once a leading product in lawn and garden care, Roundup's popularity plummeted as scientific studies began to reveal troubling links to various types of cancer, most notably non-Hodgkin lymphoma.

The legal battle began with significant verdicts in favor of plaintiffs, including a notable $10 billion settlement. However, the litigation did not end there. Bayer's strategy involved contesting cases vigorously in court, resulting in a series of trial wins that initially seemed to lower the expected settlement amounts. Nevertheless, recent victories by plaintiffs have shifted the pendulum back, raising the anticipated settlements.

As of early 2024, the Roundup MDL remains a focal point in mass tort litigation. The continued success of plaintiffs in recent trials suggests that Bayer may face higher settlement demands moving forward. For those navigating this litigation, Law Firm Connector offers resources to connect clients with experienced attorneys who specialize in mass torts, helping to streamline the legal process for all parties involved.

Paraquat (S.D. Illinois 3:21-md-3004)

The Paraquat MDL involves lawsuits alleging that exposure to this industrial herbicide causes Parkinson’s disease. Paraquat is a highly effective weed killer but has been linked to severe neurological conditions, leading to a surge in litigation. The MDL for Paraquat has been one of the fastest-growing in recent years, reflecting the seriousness of the claims and the widespread use of the herbicide.

By the end of 2023, nearly 5,000 cases were filed, with expectations for that number to grow further in 2024. The first bellwether trials are scheduled to commence this year, which could significantly influence settlement negotiations. Given the debilitating nature of Parkinson’s disease, settlements in these cases could be substantial, making this an important area of focus for legal professionals.

For those involved in the Paraquat litigation, Law Firm Connector provides a platform to find clients who have been affected by Paraquat exposure and to connect them with attorneys who are equipped to handle these complex cases.

Paragard IUD (N.D. Georgia 1:20-md-2974)

The Paragard IUD litigation centers on allegations that defects in the device caused severe health complications for users. Paragard is a non-hormonal intrauterine device used for birth control, but claims suggest that its design flaws may lead to the breakage of retainer arms during removal, causing significant internal damage.

The MDL for Paragard IUD is known for its slow pace, with the number of cases growing steadily but slowly. As of early 2024, approximately 2,200 cases are pending. The first bellwether trials are expected towards the end of 2024, which could potentially accelerate the settlement process. Given the nature of the claims and the impact on women's health, significant developments are anticipated in this MDL.

Attorneys and clients navigating the Paragard litigation can benefit from the resources available through Law Firm Connector, which helps match clients with specialized attorneys experienced in handling complex mass tort cases.

Firefighting Foam (AFFF) (D. South Carolina 2:18-mn-2873)

Aqueous Film-Forming Foam (AFFF) lawsuits allege that exposure to this firefighting foam is linked to certain types of cancer. The MDL for AFFF was consolidated in the District of South Carolina, and 2023 saw significant developments, including a global settlement for water contamination claims. This settlement addressed claims brought by municipalities and water authorities but did not cover individual cancer cases.

As we enter 2024, the focus shifts to the individual cancer claims. Although a global settlement for these cases has not yet materialized, speculation suggests that negotiations could intensify this year. The resolution of these claims could have far-reaching implications for both plaintiffs and defendants.

For those involved in AFFF litigation, Law Firm Connector offers tools to help connect clients with attorneys who specialize in environmental and product liability cases, facilitating access to legal representation for those affected by AFFF exposure.

Hernia Mesh (C.R. Bard MDL, S.D. Ohio 2:18-md-2846)

Hernia mesh lawsuits are focused on allegations that defective mesh implants used in hernia repair surgeries caused complications and injuries. The largest MDL for these cases involves C.R. Bard, with over 20,000 cases currently pending. The litigation has faced periods of stagnation, but recent developments include a notable bellwether trial verdict.

The outcome of the January 2024 bellwether trial could play a crucial role in shaping future settlement negotiations. The sheer volume of pending cases adds complexity to any potential global settlement, but significant settlements could be on the horizon if favorable verdicts continue.

For legal professionals handling hernia mesh cases, Law Firm Connector can assist in finding clients who have been affected and provide resources for connecting with attorneys who are well-versed in hernia mesh litigation.

CPAP Machine Recall (W.D. Pennsylvania 2:21-mc-1230)

The CPAP machine recall litigation emerged after Philips recalled millions of CPAP and BiPAP devices due to a defect that caused users to inhale toxic chemicals from deteriorating sound abatement foam. The MDL began with a relatively small number of cases, but that number has since grown to nearly 800.

While significant developments in the CPAP litigation are not expected in 2024, the volume of new filings continues to increase. This ongoing growth reflects the continued impact of the recall on users and suggests that the MDL will remain active in the coming year.

For those involved in CPAP litigation, Law Firm Connector provides a valuable resource for finding legal representation and connecting clients with attorneys who specialize in product liability and recall cases.

Talcum Powder (D. New Jersey 3:16-md-02738)

The talcum powder litigation against Johnson & Johnson revolves around claims that talc in products like baby powder causes cancer, including ovarian cancer. The MDL for these cases is one of the largest in the country, with over 50,000 cases pending. Despite J&J's attempts to settle the cases cheaply with a $9 billion offer, plaintiffs continue to push for a more substantial resolution.

2024 could be a pivotal year for this litigation as ongoing trials generate pressure on J&J to reach a more comprehensive settlement. The large number of pending cases and the substantial verdicts in trials suggest that significant developments may be on the horizon.

Attorneys and clients dealing with talcum powder cases can benefit from Law Firm Connector, which helps connect those affected by talc exposure with experienced legal professionals.

Tepezza (N.D. Illinois 1:23-cv-03568)

Tepezza, a prescription drug used for thyroid eye disease, has been linked to permanent hearing loss. The MDL for Tepezza is relatively new, with fewer than 100 cases currently filed. However, the litigation is expected to grow as more individuals come forward with claims.

2024 is anticipated to be a significant year for Tepezza litigation as the number of cases increases and legal proceedings advance. The potential for substantial settlements remains high due to the severity of the reported side effects.

For those navigating Tepezza litigation, Law Firm Connector offers a platform to connect clients with attorneys who specialize in handling drug-related injury cases.

Exactech Knee & Ankle Recall (E.D. New York 1:22-md-03044)

Exactech’s recall of knee and ankle implants due to defects in packaging has led to a growing MDL. The number of cases surged from 123 at the beginning of 2023 to 883, with additional cases pending in state courts. The recall, which affected implants used in total knee and ankle replacement surgeries, has generated a significant volume of litigation.

As we move into 2024, the Exactech MDL is expected to continue expanding, with more cases anticipated. The substantial increase in filings indicates ongoing concerns about implant failures and the potential for high settlements.

For those involved in Exactech litigation, Law Firm Connector provides resources to help connect clients with attorneys experienced in product liability and recall cases.

Hair Relaxer (N.D. Illinois 1:23-cv-00818)

Hair relaxer products have come under fire following a groundbreaking study linking their use to an increased risk of uterine cancer. The MDL for hair relaxer cases experienced explosive growth in 2023, with the number of pending cases rising from fewer than 150 to over 9,000.

This rapid expansion is expected to continue into 2024 as more women who used hair relaxers come forward with claims. The size of the potential settlement pool and the seriousness of the health issues involved make this an important area of focus for both plaintiffs and defendants.

For legal professionals handling hair relaxer cases, Law Firm Connector offers tools to find clients who have been affected and connect them with attorneys skilled in handling such mass tort cases.

Suboxone Tooth Decay (N.D. Ohio 1:24-md-03092)

Suboxone, a medication used to treat opioid addiction, has been associated with severe tooth decay due to its formulation. The MDL for Suboxone is expected to consolidate soon, with thousands of cases anticipated as more individuals come forward with similar claims.

The 2024 litigation landscape for Suboxone will likely see significant developments as the MDL is established and cases begin to progress. The potential impact on users and the healthcare system makes this an area to watch closely.

Attorneys and clients involved in Suboxone litigation can benefit from Law Firm Connector, which can help connect those affected by Suboxone-related injuries with experienced legal representation.

Bard PowerPort (D. Arizona 2:23-md-03081)

The Bard PowerPort, a device used for frequent intravenous access, has faced lawsuits over design defects that allegedly caused serious injuries. The MDL for Bard PowerPort cases is relatively small, with fewer than 100 cases filed so far. However, the litigation is expected to grow as more plaintiffs come forward.

2024 may bring substantial developments in this MDL as the number of cases increases and legal proceedings advance. The severity of the reported injuries could lead to significant settlements or verdicts.

For those navigating Bard PowerPort litigation, Law Firm Connector offers resources to help connect clients with attorneys who specialize in medical device litigation.

As we move through 2024, the landscape of mass torts and MDLs is expected to evolve rapidly. Each of these litigations presents unique challenges and opportunities for plaintiffs and defendants alike. Navigating these complex cases requires expert legal representation and access to specialized resources.

If you are an attorney looking to connect with clients affected by these issues, or a client seeking the right legal representation, consider exploring Law Firm Connector. This platform provides valuable tools to facilitate connections between clients and attorneys, ensuring that those affected by mass torts and MDLs have access to the support they need.

By staying informed about these key cases and leveraging resources like Law Firm Connector, you can better navigate the complexities of mass tort litigation and position yourself for success in the evolving legal landscape of 2024.